Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
Open accessThe DOI matches its Crossref record; 267 of the 267 references it cites were found in a registry or an index.
Abstract
Inflammatory bowel disease (IBD) is a chronic complex inflammatory gut pathological condition, examples of which include Crohn’s disease (CD) and ulcerative colitis (UC), which is associated with significant morbidity. Although the etiology of IBD is unknown, gut microbiota alteration (dysbiosis) is considered a novel factor involved in the pathogenesis of IBD. The gut microbiota acts as a metabolic organ and contributes to human health by performing various physiological functions; deviation in the gut flora composition is involved in various disease pathologies, including IBD. This review aims to summarize the current knowledge of gut microbiota alteration in IBD and how this contributes to intestinal inflammation, as well as explore the potential role of gut microbiota-based treatment approaches for the prevention and treatment of IBD. The current literature has clearly demonstrated a perturbation of the gut microbiota in IBD patients and mice colitis models, but a clear causal link of cause and effect has not yet been presented. In addition, gut microbiota-based therapeutic approaches have also shown good evidence of their effects in the amelioration of colitis in animal models (mice) and IBD patients, which indicates that gut flora might be a new promising therapeutic target for the treatment of IBD. However, insufficient data and confusing results from previous studies have led to a failure to define a core microbiome associated with IBD and the hidden mechanism of pathogenesis, which suggests that well-designed randomized control trials and mouse models are required for further research. In addition, a better understanding of this ecosystem will also determine the role of prebiotics and probiotics as therapeutic agents in the management of IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alterations in sex hormones levels may lead to microbial dysbiosis which has been previously implicated in IBD and its symptom severity.(40)”
From Association Between Sex Hormone Levels and Gut Microbiota Composition and Diversity—A Systematic Review (2022) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 3×
“25% (fewer) of the mucosal microbial genes of healthy individuals [25].”
BackgroundInfluentialChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087 · cited 1×
“The highest incidence rate has been recorded in developed countries, such as North America, Europe, Australia, and New Zealand [6], while recently, IBD has been gradually becoming more common in developing areas such as Asia and South America, and in developing countries such as including Brazil, South Korea, and Chin…”
BackgroundAssociation of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591 · cited 2×
“The NOD2 (nucleotide-binding oligomerization domain containing protein 2), a first gene locus, has been reported as a risk locus for Crohn’s disease (CD) [175,176].”
BackgroundDe Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579 · cited 1×
“Human Bacteroidetes Firmicutes, Enterobacteriaceae Decrease Increase [163]”
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030 · cited 1×
“The NOD2 (nucleotide-binding oligomerization domain containing protein 2), a first gene locus, has been reported as a risk locus for Crohn’s disease (CD) [175,176].”
BackgroundDiarrheagenic Escherichia coli
Nataro, J. P., & Kaper, J. B. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.1.142 · Cited by 5,006 · cited 1×
“Many studies in human IBD patients have reported the commensal bacteria association with the patient’s intestines; for example, an association of adherent/invasive Escherichia coli (AIEC), a normal gut flora of the Enterobacteriaceae group, has been found with CD [121].”
BackgroundMetabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838 · cited 1×
“In addition, certain symbiotic gut microbiota members have been reported to have distinct and specific effects on the host immune system, and are considered key to immune homeostasis [31,37,38].”
BackgroundHost–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722 · cited 1×
“Genome-wide association studies (GWAS) have identified more than 160 genetic loci associated with conferring protection from IBD or increased risk to IBD development [172].”
BackgroundRichness of human gut microbiome correlates with metabolic markers
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.-M., Kennedy, S., et al. (2013) · Nature · doi:10.1038/nature12506 · Cited by 4,662
Research works printed but not linked: 2
- Zhang, 2007, Wumei pill decoction in the treatment of 72 cases of chronic nonspecific ulcerative colitis, Mod. J. Integr. Tradit. West. Med., 16, 5156
- Yan, 2013, Effect of Astragalus Polysaccharides on Th17/Treg Cytokines and Pulmonary Inflammation in Asthmatic Rats, Chin. Pharmacol. Bull., 29, 1275
Cited by
Items 301–400 of 804
Healing from Within: How Gut Microbiota Predicts IBD Treatment Success—A Systematic Review
Alexandrescu, L., Nicoara, A. D., Tofolean, D. E., Herlo, A., Twakor, A. N., Tocia, C., Trandafir, A., Dumitru, A., Dumitru, E., Aftenie, C. F., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158451 · Cited by 23
“These discoveries have caused a fundamental change in the approach to treating this condition, focusing on the goal of restoring the equilibrium of microorganisms in the gut [28,29].”
BackgroundExploring the Connections: Autophagy, Gut Microbiota, and Inflammatory Bowel Disease Pathogenesis
Subramanian, A., Jahabardeen, A., Thamaraikani, T., Kumarasamy, V., Begum, M. Y., Sekar, M., Subramaniyan, V., Wong, L. S., & Fatease, A. M. A. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s483958 · Cited by 22
“18 Additionally, individuals with IBD experience alterations in the composition and function of their gut microbiota, which further exacerbates the inflammatory response.”
Alioui, Y., Ullah, H., Ali, S., Rahman, M. U., Elkharti, M., Farooqui, N. A., Rehman, A. U., Ilyas, M., Alsholi, D. M., Siddiqi, N. Z., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1498625 · Cited by 21
Fernandes, P., Sharma, Y., Zulqarnain, F., McGrew, B., Shrivastava, A., Ehsan, L., Payne, D., Dillard, L. R., Powers, D. A., Aldridge, I., et al. (2023) · Scientific Reports · doi:10.1038/s41598-022-26816-5 · Cited by 19
Ткач, С. М., Dorofeyev, A., Kuzenko, I., Falalyeyeva, T. M., Tsyryuk, O., Kovalchuk, O. I., Kobyliak, N. M., Abenavoli, L., & Boccuto, L. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1049849 · Cited by 19
“It is possible that the severity of gut dysbiosis in patients with UC largely determines the clinical picture of the disease, the severity of exacerbation, and the stability of remission (9).”
Lin, A., Inman, R. D., Streutker, C., Zhang, Z., Pritzker, K. P. H., Tsui, H. W., & Tsui, F. W. L. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02149-4 · Cited by 19
Habiballah, D. N., Li, F., & Jiang, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1602235 · Cited by 20
Ferrari, E., Monzani, R., Saverio, V., Gagliardi, M., Pańczyszyn, E., Raia, V., Villella, V. R., Bona, G., Pane, M., Amoruso, A., et al. (2021) · Nutrients · doi:10.3390/nu13041221 · Cited by 18
van Meijel, R. L. J., Venema, K., Canfora, E. E., Blaak, E. E., & Goossens, G. H. (2022) · Beneficial Microbes · doi:10.3920/bm2021.0159 · Cited by 19
Bennike, T. B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1254948 · Cited by 18
Genomic analyses of Bacteroides fragilis: subdivisions I and II represent distinct species
English, J., Newberry, F., Hoyles, L., Patrick, S., & Stewart, L. D. (2023) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001768 · Cited by 21
Zou, C., Zan, X., Jia, Z., Zheng, L., Gu, Y., Liu, F., Han, Y., Xu, C., Wu, A., & Zhi, Q. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1479 · Cited by 19
“34,35 38 Notably, several studies have found that defects in RNA splicing are also linked to the dysbiosis of intestinal microbiota and contribute partly to the pathogenesis of IBD.”
BackgroundIlan, K., Motro, Y., Nemirovsky, A., Schwartz, D., Goren, G., Sergienko, R., Greenberg, D., Slonim‐Nevo, V., Sarid, O., Friger, M. D., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2337269 · Cited by 20
Jurjus, A. R., Masri, J. E., Ghazi, M., Ayoubi, L. M. E., Soueid, L., Geagea, A. G., & Jurjus, R. A. (2024) · Nutrients · doi:10.3390/nu16081236 · Cited by 23
“Several harmful bacteria were found to be responsible for IBD pathogenesis, such as Firmicutes (abundant in bare sand), Proteobacteria , and Roseburia spp., including Roseburia faecis and Roseburia intestinalis [19].”
BackgroundMoncada, E., Bulut, N., Li, S., Johnson, T. A., Hamaker, B. R., & Reddivari, L. (2024) · Nutrients · doi:10.3390/nu16152446 · Cited by 19
Yang, X., He, M., Cao, J., Tang, Q., Yang, B., Li, T., & Sun, M. (2024) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x24500745 · Cited by 18
Probiotic supplementation: A prospective approach in the treatment of COVID-19
Nayebi, A., Navashenaq, J. G., Soleimani, D., & Nachvak, S. M. (2021) · Nutrition and Health · doi:10.1177/02601060211049631 · Cited by 19
Cai, H., Liao, S., Li, J., Liu, Q., Luo, S., Lv, M., Lin, X., Hu, J., Zhang, J., Qi, N., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.811428 · Cited by 19
Krela‐Kaźmierczak, I., Zakerska‐Banaszak, O., Skrzypczak-Zielińska, M., Łykowska‐Szuber, L., Szymczak‐Tomczak, A., Zawada, A. E., Rychter, A. M., Ratajczak, A. E., Skoracka, K., Skrzypczak, D., et al. (2022) · Nutrients · doi:10.3390/nu14122520 · Cited by 19
The oft-overlooked cardiovascular complications of inflammatory bowel disease
Massironi, S., Mulinacci, G., Gallo, C., Viganò, C., Fichera, M., Villatore, A., Peretto, G., & Danese, S. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2174971 · Cited by 22
“some similarities with alterations of the microbiota in IBD [45].”
Wu, G., Wang, R., Wang, Y., Sun, S., Chen, J., & Zhang, Q. (2025) · Foods · doi:10.3390/foods14223836 · Cited by 20
“These mucins, upon glycosylation, form glycan structures that serve as key carbon sources for certain gut bacteria (e.g., Akkermansia muciniphila and Bacteroides spp.) [20].”
Guzzo, G. L., Mittinty, M., Llamas, B., Andrews, J. M., & Weyrich, L. S. (2022) · Microorganisms · doi:10.3390/microorganisms10101910 · Cited by 20
Zhang, M., Xie, R., Wang, H., Wen, X., Wang, J., He, L., Zhang, M., & Yang, X. (2023) · Molecules · doi:10.3390/molecules28031060 · Cited by 19
Vacca, M., Sommella, E., Liso, M., Verna, G., Scarano, A., Sila, A., Curlo, M., Mastronardi, M., Petroni, K., Tonelli, C., et al. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2023.9250036 · Cited by 17
Multiple Sampling Capsule Robot for Studying Gut Microbiome
Park, S., Hoang, M. C., Kim, J., & Park, S. (2024) · Advanced Intelligent Systems · doi:10.1002/aisy.202300625 · Cited by 18
The Role of the Gut Microbiome in Inflammatory Bowel Disease: The Middle East Perspective
El-Sayed, A., Kapila, D., Taha, R. S. I., El-Sayed, S., Mahen, M. R. A., Taha, R., & Alrubaiy, L. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14060652 · Cited by 18
“REVIEW Alongside a decrease in the commensal Firmicutes , there is a significant decrease in other favourable bacterial genera, including Lactobacillus , and Eubacterium [7] (Figure 2).”
BackgroundZakerska‐Banaszak, O., Żuraszek-Szymańska, J., Eder, P., Ladziak, K., Słomski, R., & Skrzypczak-Zielińska, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179589 · Cited by 18
The Potential Role of Boron in the Modulation of Gut Microbiota Composition: An In Vivo Pilot Study
Sentürk, N. B., Kasapoğlu, B., Şahin, E., Özcan, O., Ozansoy, M., Ozansoy, M. B., Siyah, P., Sezerman, O. U., & Şahin, F. (2024) · Pharmaceuticals · doi:10.3390/ph17101334 · Cited by 18
“Gastrointestinal (GI) inflammation caused by inflammatory bowel disease (IBD) modifies the commensal microbiome [9,10].”
BackgroundZhu, C., Wang, X., Li, J., Jiang, R., Chen, H., Chen, T., & Yang, Y. (2022) · BMC Microbiology · doi:10.1186/s12866-021-02414-9 · Cited by 18
KHAN, I. A., Bai, Y., Ullah, N., Liu, G., Rajoka, M. S. R., & Zhang, C. (2022) · Advanced Gut & Microbiome Research · doi:10.1155/2022/7813278 · Cited by 24
“Although an obvious role of the gut microbiota in IBD pathogenesis has been demonstrated by the link between gut microbiota dysfunction in IBD patients and colitis models [23], unfortunately, the association of a specific core gut microbiome and a constant dysbiotic pattern that is suspected to be involved in the onse…”
BackgroundSelf-citationMahalak, K. K., Firrman, J., Tolehmurodovich, B. J., Narrowe, A. B., Bittinger, K. L., Daniel, S. G., Tanes, C., Mattei, L. M., Zeng, W.-B., Soares, J. W., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112973 · Cited by 19
A mechanism-based understanding of altered drug pharmacokinetics by gut microbiota
Gulnaz, A., Chang, J., Maeng, H., Shin, K., Lee, K., & Chae, Y. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00600-z · Cited by 18
Kriaa, A., Jablaoui, A., Rhimi, S., Soussou, S., Mkaouar, H., Mariaule, V., Gruba, N., Gargouri, A., Maguin, E., Lesner, A., et al. (2021) · Cells · doi:10.3390/cells10102658 · Cited by 16
Yang, Y., Jia, H., Lyu, W., Furukawa, K., Li, X., Hasebe, Y., & Kato, H. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.895665 · Cited by 19
Effects of kefir fermented milk beverage on sodium dextran sulfate (DSS)-induced colitis in rats
da Silva, K. N., Fávero, A. G., Ribeiro, W., Ferreira, C. M., Sartorelli, P., Cardili, L., Bogsan, C. S. B., Pereira, J. N. B., Sinigaglia, R. D. C., Malinverni, A. C. D. M., et al. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12707 · Cited by 18
Lee, S.-H., Seo, D., Lee, K.-H., Park, S.-J., Park, S., Kim, H., Kim, T., Joo, I., Park, J., Kang, Y.-H., et al. (2023) · Nutrients · doi:10.3390/nu15020319 · Cited by 17
Moon, H., Oh, S., Park, K.-B., & Cha, Y. (2023) · Foods · doi:10.3390/foods12030584 · Cited by 17
Is there a role for microbiome-based approach in common variable immunodeficiency?
Poto, R., Ianiro, G., de Paulis, A., Spadaro, G., Marone, G., Gasbarrini, A., & Varricchi, G. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01006-3 · Cited by 17
“Gut microbiota dysregulation is suggested to play a key role in the development of several disorders, including inflammatory bowel diseases [12], irritable bowel syndrome [13], metabolic diseases [14], autoimmune disorders [15] and cancer [16, 17].”
BackgroundBoicean, A., Bratu, D. G., Bacila, C. I., Tanasescu, C. A. H., Fleacă, R. S., Mohor, C. I., Comaniciu, A., Băluță, T., Roman, M. D., Chicea, R., et al. (2023) · Pathogens · doi:10.3390/pathogens12060766 · Cited by 17
Wu, D., Zhang, Y. X., Zou, B., Lü, Y., & Cao, H. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04237-9 · Cited by 16
“These cytokines inhibit the inflammatory response and induce immune tolerance in the peripheral immune system [26, 27].”
BackgroundAldo-keto reductase 1B: Much learned, much more to do
Zhao, Y., Zhang, M., Li, H., Yang, Y., Lu, X., Yu, J., & Pan, L. (2023) · hLife · doi:10.1016/j.hlife.2023.12.002 · Cited by 19
Costa‐Pérez, A., Sánchez‐Bravo, P., Medina, S., Domínguez‐Perles, R., & García‐Viguera, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020800 · Cited by 16
Faecal Microbiota Transplantation Alleviates Ferroptosis after Ischaemic Stroke
Wei, J., Wang, G., Lai, M., Zhang, Y., Li, F., Wang, Y., & Tan, Y. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.01.021 · Cited by 19
Fatakhova, K., & Rajapakse, R. O. (2024) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh-23-36 · Cited by 17
More on the interplay between gut microbiota, autophagy, and inflammatory bowel disease is needed
Subramanian, A., Jahabardeen, A., Tamilanban, T., & Vellapandian, C. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i27.3356 · Cited by 16
Underneath the Gut–Brain Axis in IBD—Evidence of the Non-Obvious
Boldyreva, L. V., Evtushenko, A. A., Lvova, M. N., Morozova, K. N., & Владимировна, К. Е. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212125 · Cited by 16
Akbarian, P., Asadi, F., & Sabahi, A. (2024) · Middle East Journal of Digestive Diseases · doi:10.34172/mejdd.2024.394 · Cited by 16
Ahmadi, A., Kouhsari, E., Razavi, S., Mohammadzadeh, N., Besharat, S., Vakili, M. A., & Amiriani, T. (2025) · New Microbes and New Infections · doi:10.1016/j.nmni.2025.101567 · Cited by 16
“Our study contributes to the understanding of the underlying mechanisms involved in gut microbiota dysbiosis in IBD([20]).”
Geese, T., Bang, C., Franke, A., Lieb, W., & Dempfle, A. (2025) · BMC Microbiology · doi:10.1186/s12866-025-04106-0 · Cited by 18
“These changes extend to the overall composition, where some bacterial taxa are observed to be either depleted or enriched in IBD patients [7].”
Wang, W., Zhai, D., Bai, Y., Xue, K., Deng, L., Ma, L., Du, T., Ye, Z., Qu, D., An, X., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00444-w · Cited by 17
Self-citationWu, L., Shen, F., Wang, W., Qi, C., Wang, C., Shang, A., & Xuan, S. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104431 · Cited by 16
Host Microbiomes in Tumor Precision Medicine: How far are we?
D’Amico, F., Barone, M., Tavella, T., Rampelli, S., Brigidi, P., & Turroni, S. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220105121754 · Cited by 17
Aghamohammad, S., Sepehr, A., Miri, S. T., Najafi, S., Pourshafie, M. R., & Rohani, M. (2022) · Letters in Applied Microbiology · doi:10.1111/lam.13793 · Cited by 17
“The balance between anti-inflammatory and proinflammatory cytokines associated with Th17 and Treg activity is necessary to prevent the development of abnormalities, including intestinal inflammation and IBD (Khan et al. 2019).”
BackgroundKiron, V., Hayes, M., & Avni, D. (2022) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2022.09.012 · Cited by 17
Kim, W.-K., Min, S.-G., Kwon, H., Park, S., Jo, M. J., & Ko, G. (2023) · The Journal of Microbiology · doi:10.1007/s12275-023-00061-5 · Cited by 16
Lycium Berry Polysaccharides Strengthen Gut Microenvironment and Modulate Gut Microbiota of the Mice
Xia, W., Li, X., Khan, I., Yin, L., Su, L., Leong, W. K., Bian, X., Su, J., Hsiao, W. L. W., & Huang, G. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/8097021 · Cited by 24
Self-citationChanges of intestinal microbiota and microbiota-based treatments in IBD
Li, Q., Zhou, S., Wang, Y., & Cong, J. (2022) · Archives of Microbiology · doi:10.1007/s00203-022-03069-4 · Cited by 16
“Commonly, heterologous fecal microbiological transplantation (h-FMT) is used to treat CDI, with a more than 90% cure rate in clinical trials (Khoruts and Sadowsky 2016; Quraishi et al.”
MethodBarron, M. R., Sovacool, K. L., Close, L. A., Vendrov, K. C., Standke, A. K., Bergin, I. L., Schloss, P. D., & Young, V. B. (2022) · mBio · doi:10.1128/mbio.01904-22 · Cited by 16
“described here, and by others, as being linked with CDI development (63, 64).”
BackgroundCheng, H., Yuan, Y., Hu, J., Chen, L., Yuan, M., Du, H., Xu, Z., & Qiu, Z. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122901 · Cited by 16
Li, Y., Li, Z., Sun, Q., Wang, L., & Ning, S. (2024) · Gut Pathogens · doi:10.1186/s13099-024-00633-9 · Cited by 16
“The report claimed that the dysbiosis pattern of UC often manifests as a decrease in bacterial diversity and the abundance of symbiotic bacteria such as Bifidobacteria , Bacteroides , Eubacteria , and an increase in Firmicutes (especially Clostridium ) and Proteobacteria [3–5].”
BackgroundTouny, A. A., Venkataraman, B., Ojha, S. K., Pessia, M., Subramanian, V. S., gowdru, S. N. H., & Subramanya, S. B. (2024) · Nutrients · doi:10.3390/nu16213633 · Cited by 17
The Role of Vitamin D in Gastrointestinal Homeostasis and Gut Inflammation
Vemulapalli, V., & Thomas, A. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073020 · Cited by 17
“These variables should be controlled before making definitive conclusions on the effects of Vitamin D on gut microbiota.”
Nong, F., Luo, S., Liang, Y., Zhao, Z., Xing, S., Wen, B., & Zhou, L. (2020) · Biomedical Chromatography · doi:10.1002/bmc.5003 · Cited by 16
Venkatakrishnan, A., Holzknecht, Z. E., Holzknecht, R. A., Bowles, D. E., Kotzé, S. H., Modliszewski, J. L., & Parker, W. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.01.007 · Cited by 15
“Thus, an unhealthy gut microbiota is often difficult to identify [4], and mystery surrounds exactly where such a microbiota may have originated.”
BackgroundBochart, R. M., Busman‐Sahay, K., Bondoc, S., Morrow, D. W., Ortiz, A. M., Fennessey, C. M., Fischer, M. B., Shiel, O., Swanson, T., Shriver-Munsch, C. M., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009565 · Cited by 15
Mörschbächer, A. P., Pappen, E., Henriques, J. A. P., & Granada, C. E. (2023) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202320230037 · Cited by 16
“…(Foster et al. 2017), gastrointestinal cancer (Elsalem et al. 2020), obesity (Maruvada et al. 2017), autism spectrum disorder (Sivamaruthi et al. 2020), cardiovascular disease (Tang et al. 2017), inflammatory bowel disease (Khan et al. 2019), and Parkinson’s disease (Parashar & Udayabanu 2017).”
BackgroundHerrera, M., & Byerley, L. O. (2025) · Nutrients · doi:10.3390/nu17142373 · Cited by 15
“The etiology of IBD is complex and not completely understood, but it is believed to be an interaction of genetic predisposition, environmental triggers, immune system malfunctions, and disruptions in the gut microbiome [3].”
Probiotics in IBD: Evidence and Perspectives on Patient Health and Disease Management
Hijová, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189065 · Cited by 14
“Probiotics, or beneficial live microorganisms, have shown promise in prevention and treatment of inflammatory bowel diseases by promoting balance in the intestinal microbiota and increasing its diversity and composition, thereby contributing to the prevention or reduction of dysbiosis [40].”
Systems biology to unravel Western diet-associated triggers in inflammatory bowel disease
Konjar, Š., Benedik, E., Šestan, M., Veldhoen, M., & Županič, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1621334 · Cited by 15
Nogués, E. B., Kropp, C., Bétemps, L., de Sousa, C. S., Chain, F., Auger, S., Azevedo, V., Langella, P., & Chatel, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-19455-3 · Cited by 14
Wen, C., Zhang, F., Yang, K., Han, S., Jian, S., & Deng, B. (2023) · Animal Research and One Health · doi:10.1002/aro2.21 · Cited by 15
Lin, Z., Luo, W. T., Zhang, K., & Dai, S. (2023) · Gut and Liver · doi:10.5009/gnl230179 · Cited by 18
“95,96 The functional disorder of the gut microbiome in IBD patients will cause a series of reactive changes in the body, mainly including the reduction of SCFAs and amino acids synthesized by microbes, increased oxygen consumption, increased sulfate transport, and malnutrition.”
BackgroundLiu, T., Feng, J., Han, H., Huang, J., Zhang, L., Hettinga, K. A., & Zhou, P. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.103375 · Cited by 15
Deli, C. K., Fatouros, I. G., Poulios, A., Liakou, C. A., Draganidis, D., Παπανικολάου, Κ., Rosvoglou, A., Gatsas, A., Georgakouli, K., Tsimeas, P. D., et al. (2024) · Life · doi:10.3390/life14081016 · Cited by 17
Yi, D., Li, T., Xiao, Y., Zhang, X., Hao, Q., Zhang, F., Qiu, T., Yang, G., Sun, X., Dong, Y., et al. (2024) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10728 · Cited by 16
Ma, M., Zhang, S., Li, J., Zhao, L., Song, D., Ma, P., & Jin, X. (2024) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2024.137057 · Cited by 14
Propionate Fermentative Genes of the Gut Microbiome Decrease in Inflammatory Bowel Disease
Medina, J. M., Fernández-López, R., Crespo, J., & de la Cruz, F. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102176 · Cited by 15
“However, the species involved and the magnitude and sign of the changes observed are highly variable, and most taxa appear to increase their numbers in some studies, but decreasing in others [3].”
BackgroundMucolytic bacteria: prevalence in various pathological diseases
Selwal, K. K., Selwal, M. K., & Yu, Z. (2021) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-021-03145-9 · Cited by 14
Nausch, B., Bittner, C. B., Höller, M., Abramov-Sommariva, D., Hiergeist, A., & Gessner, A. (2022) · Antibiotics · doi:10.3390/antibiotics11101331 · Cited by 15
Estevinho, M. M., Cabeda, J. M., Santiago, M., Machado, E., Silva, R., Duro, M., Pita, I., Morais, R., Macedo, G., Bull, T. J., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11061520 · Cited by 15
Immunostimulating Commensal Bacteria and Their Potential Use as Therapeutics
McCuaig, B., & Goto, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115644 · Cited by 15
Tang, Q., & Evans, R. M. (2021) · Essays in Biochemistry · doi:10.1042/ebc20210038 · Cited by 14
Nutraceuticals in the Modulation of the Intestinal Microbiota: Current Status and Future Directions
Spisni, E., Turroni, S., Alvisi, P., Spigarelli, R., Azzinnari, D., Ayala, D., Imbesi, V., & Valerii, M. C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.841782 · Cited by 16
Next-Generation Sequencing to Elucidate the Semen Microbiome in Male Reproductive Disorders
Davies, R., Minhas, S., & Jayasena, C. N. (2023) · Medicina · doi:10.3390/medicina60010025 · Cited by 13
“It is known, for example, in research on the gut microbiota, that it is affected by age, ethnicity, diet, systemic conditions and genetics [15,23,58].”
BackgroundNayman, E. I., Schwartz, B. A., Polmann, M. B., Gumabong, A. C., Nieuwdorp, M., Cickovski, T., & Mathee, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-54769-4 · Cited by 13
Boppana, K., Almansouri, N. E., Bakkannavar, S., Faheem, Y. A. M., Jaiswal, A., Shergill, K., & Nath, T. S. (2024) · Cureus · doi:10.7759/cureus.58080 · Cited by 13
“These fatty acids serve as a carbon source for intestinal colonocytes and aid in the differentiation of regulatory T cells (Tregs) [14,15].”
BackgroundZinc and Inflammatory Bowel Disease: From Clinical Study to Animal Experiment
Peng, X., Yang, Y., Zhong, R., Yang, Y., Fang, Y., Liang, N., & Yuan, S. (2024) · Biological Trace Element Research · doi:10.1007/s12011-024-04193-6 · Cited by 13
“Furtherly, gut microbiota-based therapeutic approaches might be used for the treatment of IBD [61].”
Liu, Z., Luo, S., Liu, C., & Hu, X. (2024) · Food & Function · doi:10.1039/d4fo00531g · Cited by 13
Zahrani, A. J. A., Shori, A. B., & Al-Judaibi, E. A. (2024) · Nutrients · doi:10.3390/nu16203478 · Cited by 14
Impact of Microbiota Diversity on Inflammatory Bowel Disease
Zahrani, A. J. A., Al-Hebshi, B. M., Yahia, Z. A., Al-Judaibi, E. A., Alsaadi, K. H., & Al-Judaibi, A. A. (2025) · Microorganisms · doi:10.3390/microorganisms13040710 · Cited by 15
“Individuals with IBD often exhibit altered gut microbiota compared with healthy individuals, with a higher prevalence of certain bacterial species such as Bacteroides [3,17].”
Targeting ectonucleotidases to treat inflammation and halt cancer development in the gut
Longhi, M. S., Feng, L., & Robson, S. C. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114417 · Cited by 13
Yang, C., Sung, J. J., Long, D., Alghoul, Z., & Merlin, D. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061233 · Cited by 13
The Role of Gut Microbiota in Inflammatory Bowel Disease-Current State of the Art
Safarpour, A. R., Askari, H., Shojaei‐Zarghani, S., Raeis-Abdollahi, E., Jahromi, H. K., Raise‐Abdullahi, P., Daliri, K., Tajbakhsh, A., & Rahmati, L. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220914093331 · Cited by 15
Axl alleviates DSS-induced colitis by preventing dysbiosis of gut microbiota
Yee, S., Choi, H., Seon, J.-E., Ban, Y.-J., Kim, M. J., Seo, J.-E., Seo, J. H., Kim, S., Moon, S.-H., Yun, C., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-32527-2 · Cited by 13
Perri, M. R., Romano, C., Marrelli, M., Zicarelli, L., Toma, C.-C., Basta, D., Conforti, F., & Statti, G. A. (2021) · Plants · doi:10.3390/plants11010004 · Cited by 17
Research trends in ulcerative colitis: A bibliometric and visualized study from 2011 to 2021
Zhang, T., Zhang, B., Tian, W., Wang, F., Zhang, J., Ma, X., Wei, Y., & Tang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.951004 · Cited by 14
“…dysbiosis of the gut microbiota (predominantly bacteria) in the pathogenesis of UC and FMT as a therapeutic strategy for UC (Blanchaert et al., 2019; Khan et al., 2019; Guo et al., 2020; Liu et al., 2021); 5) diagnostic criteria and differential diagnoses for UC (Smith et al., 2020; Wang et al.,…”
BackgroundZatorski, H., & Nakov, R. (2020) · Current Drug Targets · doi:10.2174/1389450121666200602125507 · Cited by 13
Hossen, I., Wu, H., Mehmood, A., Raka, R. N., Jingyi, S., Jin, J., Xu, M., Shakoor, A., Yanping, C., Wang, C., et al. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgaa044 · Cited by 13
Zhang, L., Chen, G., Zeng, X., Yue, H., Zheng, Q., Hu, Q., Tian, Q., Liang, L., Zhao, X., Yang, Z., et al. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae063 · Cited by 16
Yan, S., & Dong, R. (2024) · Metabolites · doi:10.3390/metabo14070351 · Cited by 13
“This imbalance disrupts the symbiotic equilibrium between the intestinal microbiota and the host, essential for maintaining intestinal barrier integrity, modulating immune functions, and facilitating metabolic processes [10].”
Background
Metadata
- Authors
- Khan, I., Ullah, N., Zha, L., Bai, Y., Khan, A., Zhao, T., Che, T., & Zhang, C.
- Affiliations
- Lanzhou University (CN)
- Gansu Key Laboratory of Functional Genomics and Molecular Diagnosis, Lanzhou 730000, China
- Corresponding author
- Zhang, Chunjiang
- Venue
- Pathogens
- Publisher
- MDPI AG
- Published
- 2019-08-13
- Volume
- 8
- Issue
- 3
- Pages
- 126
- ISSN
- 2076-0817 (ISSN-L)
- PMC
- PMC6789542
- OpenAlex
- W2966933380
- Cited by
- 771
- References
- 267
- Citations by year
- 2026: 43 · 2025: 105 · 2024: 149 · 2023: 134 · 2022: 135 · 2021: 132 · 2020: 66 · 2019: 7
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lanzhou University Institutional Repository (submittedVersion, cc-by-nc-sa)
- Lanzhou University Institutional Repository (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Jiangsu Science and Technology Major Project ((No. BA2016036))
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- inflammatory bowel disease, gut microbiota, dysbiosis, Crohn's disease, ulcerative colitis, intestinal inflammation, microbiota-based therapy, probiotics, prebiotics, mouse colitis model, IBD pathogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.